10. Mar 2021 News Just four and a half years after start coparion is ranked among the 10 most powerful VC growth investors in the DACH region
9. Mar 2021 News Softbank, Demetar and coparion invest $3M into Plan A‘s B2B carbon monitoring and ESG platform
25. Feb 2021 News Protembis announces completion of 20 cases in European CE mark study with the ProtEmbo® Cerebral Protection System
28. Jan 2021 News CatalYm Starts First-in-Human Phase I Clinical Trial with GDF-15 Neutralizing Antibody CTL-002 to Treat Patients with Checkpoint- Inhibitor Refractory Cancer
